Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, Inc. (IRD), sold 4,000,000 shares at $2.15 ($8.6M) on 2025-12-09, disclosed to the SEC on 2025-12-11.
Open-market sale of $8.6M IRD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.